Evaluation of RC28-E Injection in Diabetic Retinopathy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a randomized, open-label, multicenter study of the efficacy and safety of RC28-E injection (a chimric decoy receptor trap fusion protein by dual blockage of VEGF and FGF-2) in the treatment of patients with moderately severe to severe nonproliferative diabetic retinopathy.
Epistemonikos ID: f44f9c76a5767ab677e469d2c080b3417db8f620
First added on: May 08, 2024